Key result
Smoking is associated with better attention in COPD vs non-smokers, mediated by the left fusiform gyrus.
Why the study?
Although COPD-smoking comorbidity is common, the relationship between smoking and cognitive function such as attention in this population remains unclear.
Does smoking alter attention performance and brain functional connectivity in patients with COPD?
Cross-Sectional (n=85)
No
Does smoking alter attention performance and brain functional connectivity in patients with COPD?
Smoking in COPD patients is associated with altered attention and lower regional homogeneity in the fusiform gyrus.
Answers are grounded in this paper and cite their sources.
May indicate attention advantages in smoking COPD patients; hypothesis-generating for fusiform gyrus mediation and requires causal studies.
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes a wide range of cognitive impairments. Although COPD-Smoking comorbidity is common, the relationship between smoking and cognitive function in COPD-Smoking comorbidity remains unclear. This study aimed to investigate the effect of smoking on cognitive function like attention in COPD-Smoking patients. METHODS: In this study, we used the Montreal Cognitive Assessment (MoCA) scale and resting-state functional magnetic resonance imaging (fMRI) to explore the effect of smoking on attention in patients with COPD. RESULTS: Behavioral analysis revealed that among patients with COPD the smokers had a shorter course of COPD and showed a worse attention performance than the non-smokers. Resting-state fMRI analysis revealed that among patients with COPD smokers showed lower regional homogeneity (ReHo) value of the fusiform gyrus than non-smokers. Importantly, the ReHo of the fusiform gyrus is positively associated with attention and mediates the effect of smoking on attention in COPD. CONCLUSIONS: In summary, our study provides behavioral and neurobiological evidence supporting the positive effect of smoking on attention in COPD. This may be helpful for understanding and treating COPD and even other diseases comorbid with smoking.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2022) conducted a cross-sectional in Chronic obstructive pulmonary disease (COPD) (n=85). Smoking vs. Non-smoking was evaluated on Attention ability score (MoCA scale) (Cohen's d 0.781, p=0.016). Among patients with COPD, smoking was associated with significantly higher attention ability scores compared to non-smoking (5.15 vs 4.32, p=0.016), an effect mediated by the left fusiform gyrus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: